Arylpyrazine compounds are provided, including arylpyrazines that can bind with high affinity and high selectivity to CRF1 receptors, including human CRF1 receptors. The invention thus includes methods for treatment of disorders and diseases associated with CRF1 receptors, including CNS-related disorders and diseases, particularly affective disorders and diseases, and acute and chronic neurological disorders and diseases.

 
Web www.patentalert.com

< Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5

< Modulators of paraptosis and related methods

> Method and treatment with ketoprofen solution

> Cosmetic or dermatological composition comprising an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one anti-inflammatory compound
~ 00238